Mar 5, 2026 05:31PM
Feb 16, 2026 05:31PM
Jan 12, 2026 08:09AM
Jan 12, 2026 08:00AM
Nov 24, 2025 09:00AM
Nov 12, 2025 09:00AM
Sep 29, 2025 09:00AM Connect Biopharma Presents Data Supporting Rademikibart at the European Respiratory Society Congress 2025
Sep 4, 2025 08:00AM
Sep 3, 2025 08:03AM
Sep 3, 2025 08:00AM
Aug 27, 2025 09:00AM
Aug 14, 2025 08:00AM
Aug 13, 2025 09:00AM
Jul 22, 2025 09:15AM Connect Biopharma adds Jim Schoeneck to board of directors
Jul 22, 2025 09:00AM
Jul 21, 2025 09:02AM
Jul 21, 2025 09:00AM
Jul 18, 2025 09:00AM
Jul 9, 2025 09:02AM
Jul 9, 2025 09:00AM
Jun 13, 2025 09:01AM Connect Biopharma (CNTB) Presents Data Supporting Rademikibart
Jun 13, 2025 09:00AM
May 28, 2025 09:00AM
May 20, 2025 09:00AM
May 15, 2025 09:00AM
May 14, 2025 09:00AM
May 13, 2025 09:08AM
May 13, 2025 09:00AM Connect Biopharma Initiates Phase 2 Seabreeze STAT Asthma Study Evaluating Rademikibart for the Treatment of Acute Exacerbations in Asthma
Apr 24, 2025 09:00AM
Apr 11, 2025 09:00AM
Apr 1, 2025 09:02AM
Apr 1, 2025 09:00AM
Mar 31, 2025 04:05PM
Mar 31, 2025 04:05PM
Mar 31, 2025 09:00AM Connect Biopharma Reports 2024 Full-Year Financial Results and Provides Business Update
Mar 28, 2025 04:06PM
Mar 28, 2025 04:05PM
Sep 6, 2024 06:56AM
Sep 5, 2024 04:05PM
Jun 12, 2024 04:15PM
Jun 12, 2024 04:15PM
May 22, 2024 04:05PM Connect Biopharma Presents Late-Breaking Abstract at the American Thoracic Society 2024 International Conference on the Positive Rademikibart Data from its Global Phase 2b in Patients with Moderate-to
Apr 17, 2024 06:48AM
Apr 16, 2024 04:05PM
Dec 12, 2023 06:01AM
Dec 12, 2023 06:00AM
Nov 23, 2023 02:35AM
Sep 12, 2023 04:15PM
Oct 20, 2022 08:00AM Recludix Pharma Announces the Appointment of Accomplished Immunologist and Pharmacologist Paul A. Smith, Ph.D., as Senior Vice President of Biology
Sep 13, 2022 04:05PM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All